Medicinal Products

Ikatibant Teva 30 mg otopina za injekciju u napunjenoj štrcaljki

Name Ikatibant Teva 30 mg otopina za injekciju u napunjenoj štrcaljki
Marketing Authorisation Number HR-H-164726004
Active Substance ikatibantacetat
Composition jedna napunjena štrcaljka od 3 ml sadrži ikatibantacetat što odgovara 30 mg ikatibanta jedan ml otopine sadrži 10 mg ikatibanta
Pharmaceutical Form otopina za injekciju u napunjenoj štrcaljki
Manufacturer Merckle GmbH, Blaubeuren, Njemačka
Marketing Authorisation Holder Teva B.V., Swensweg 5, Haarlem, Nizozemska
Marketing Authorisation Date 28.04.2026
MA Period of Validity unlimited
Classification Number UP/I-530-09/25-02/151
Registration Number 381-12-01/286-26-04
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product on medical prescription for renewable delivery
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code B06AC02
Marketing status Marketed
Shortage status Actual
SmPC download
PL download
Public Assessment Report download
Summary of risk management plan download

Packaging

Back